: TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)
CompletedOBSERVATIONAL
Enrollment
5
Participants
Timeline
Start Date
March 1, 2018
Primary Completion Date
November 1, 2019
Study Completion Date
November 1, 2019
Conditions
Cystic Fibrosis (CF)
Trial Locations (1)
80206
National Jewish Heatlh, Denver
All Listed Sponsors
lead
National Jewish Health
OTHER
NCT03445793 - : TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva) | Biotech Hunter | Biotech Hunter